Navigation Links
Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
Date:10/22/2010

SEATTLE, Oct. 22 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that the Company will host a webcast conference call Monday afternoon, October 25, 2010 at 4:00 p.m. Eastern time to provide a corporate update. Gregory A. Demopulos, M.D., chairman and chief executive officer, will provide remarks which will be followed by a question and answer session.

To access the live call by telephone, please dial 800-901-5217 (United States and Canada) or 617-786-2964 (International). The passcode is 26273994.  In addition, the live conference call will be webcast and can be accessed on the "Events" page of the Company's website at http://www.omeros.com.

A replay of the webcast will be available on the Company's website for one week.  A telephone replay will also be available for one week starting at 7:00 p.m. Eastern time on October 25, which can be accessed by dialing 888-286-8010 (United States and Canada) or 617-801-6888 (International) and entering passcode 82437761.

About Omeros Corporation

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five ongoing clinical development programs, including four from its PharmacoSurgery(TM) platform, the most advanced of which is in a Phase 3 clinical program, and one from its Addiction program. Omeros may also
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omeros to Present at the BioCentury NewsMakers Conference
2. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
3. Omeros Successfully Unlocks Orphan GPCRs
4. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
5. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
6. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
7. Daniel K. Spiegelman Elected to Board of Directors of Omeros
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
10. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
11. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced ... and facilities in response to increasing demand from ... services. During the fourth quarter of fiscal year ... capital expenditures and R&D above normal quarterly investments. ...
(Date:7/30/2014)... N.Y. , July 30, 2014 /PRNewswire-iReach/ -- ... -based medical device company, has announced today ... the velox CD™ Vascular Closure Device. Velox CD™ ... immediate hemostasis following percutaneous femoral procedures. The single ... broadly ranging in size from 5F to 8F.  ...
(Date:7/30/2014)... -- InnoPharma, Inc. today announced the first generic launch of ... injection), in Canada.  Olanzapine is indicated for the rapid ... schizophrenia or bipolar I mania. As the ... into an agreement with Sandoz Canada Inc., pursuant to ... market and distribute Olanzapine Injection in Canada ...
Breaking Medicine Technology:Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 2Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 3Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 4Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 5Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2
... SIRO Clinpharm a leading Contract Research Organization (CRO) based out ... Nimita Limaye, PhD, SIRO Vice President and Global Head, Strategic Data ... the Society for Clinical Data Management (SCDM).   "I ... I hope that I will live up to the ...
... At this year,s Annual Meeting of the American ... (NYSE: PHG, AEX: PHI) is demonstrating how the ... simplify the clinician and patient experience. ... http://www.newscom.com/cgi-bin/prnh/20091127/NY17547LOGO ) Specially designed ...
Cached Medicine Technology:SIRO Clinpharm's Nimita Limaye Elected as Chairperson of Society for Clinical Data Management (SCDM) 2Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 2Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 3Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 4
(Date:7/30/2014)... Denver, Colorado (PRWEB) July 30, 2014 Daily ... Barry promises to be an effective way to stop anxiety ... the program has already helped no less than 150,000 people ... indicates that this is a complex anxiety treatment system that ... for good. The whole method is very simple to access, ...
(Date:7/30/2014)... Rancho Cucamonga, CA (PRWEB) July 30, 2014 ... career learning how to make millions. However, like most people, ... all. Determined to find a better way, Paul carefully ... lasting wealth and those who do not. Based on the ... learned to not only improve his life and health, but ...
(Date:7/30/2014)... WHAT: , Resistance to artemisinin, the main drug ... Asia, among the Plasmodium falciparum ( ... and is likely caused by a genetic mutation ... artemisinin-based combination therapyas opposed to a standard three-day ... cases, according to findings published today in the ...
(Date:7/30/2014)... 30, 2014 Volunteers from the Church ... drug abuse this summer with massive distribution of ... can find these volunteers on Strøget, the famous Copenhagen ... for its shopping and its ambiance, some quarter of ... typical summer day. , These activities are part ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Visitors to ... contributed over $8,500 to ensure its protection. Bob Kiesendahl, ... a check to the Delaware Highlands Conservancy for donations ... The small $2-per-stay donations add up fast, as visitors ... the Upper Delaware River Region. , The Kiesendahl family ...
Breaking Medicine News(10 mins):Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2
... June 10 Law Offices of Howard G. Smith,announces ... a lead plaintiff in the,securities class action lawsuit filed ... the common stock of Healthways, Inc.,("Healthways" or the "Company")(Nasdaq: ... 2008 (the "Class Period"), including shares acquired through,the Company,s ...
... The aging process often forces older adults ... including their independence and the ability to exercise ... University of Missouri Center for Eldercare and Rehabilitation ... live better lives by developing and evaluating motion-capture ...
... Sen. Olympia Snowe,(R-ME), member of the Senate Finance ... that includes pharmacy-related provisions to provide,prompt payment of ... the,implementation of Medicaid reimbursement cuts for generic prescription,drugs. ... Pharmacy Inc. in,Camden, ME and a member of ...
... 10 Ask any entertainment or electronics,junkie and they ... while watching,your favorite TV show in HD won,t save ... (See video from Siemens (NYSE: SI ... system from Siemens is the world,s first to,utilize high-definition ...
... machine revenue seen as possible way to expand access., ... that everyone in the state should have access to ... by AARP Maryland.,In fact, 93 percent of Maryland voters ... gender and party affiliation., The same survey found ...
... Offered to Local Seniors, SAN FRANCISCO, June ... opportunity to exercise their brains through the Brain ... a partnership with San,Francisco-based Posit Science. The Brain ... processing, memory and other cognitive functions,with participants reporting ...
Cached Medicine News:Health News:Law Offices of Howard G. Smith Announces Update to the Shareholder Lawsuit Against Healthways, Inc. 2Health News:MU researchers enhancing motion-capture technology to benefit older adults 2Health News:Maine Community Pharmacy Owner Thanks Sen. Snowe for Supporting Inclusion of Common-Sense Reimbursement Provisions in Medicare Bill 2Health News:Survey: Maryland Voters Concerned About Health Care 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 3
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... The "three-in-one Microkeratome for traditional Lasik, Epi-Lasik ... a world of rapidly changing technologies and ... II is and remains a proven value, ... their needs and allows them to stay ...
Medicine Products: